Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NATCOPHARM | BSE
-2.60
-0.33%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
08/12/2023
780.15
783.20
789.90
776.45
NATCO Pharma Limited a pharmaceutical company develops manufactures and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas including cancers of blood liver kidney lung brain breast ovary etc.; and APIs in various categories such as oncology central nervous system pain management and CV care. The company also offers orthopedic products comprising bisphosphonates which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C as well as contract manufacturing services. In addition it provides cardiology and diabetology products for the treatment of hypertension stable angina and CHF; and agro chemicals and biological pest management solutions for management of insects diseases and weeds across a range of crops. The company markets its products in approximately 50 countries. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
16.2%1 month
31.0%3 months
33.8%6 months
35.1%12.50
0
2.64
0.05
0.04
8.53
3.66
0
14.33B
139.82B
1.68B
1.31
40.18
562.40
138.70
22.86
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
36.65
Range1M
141.35
Range3M
200.60
Rel. volume
0.65
Price X volume
19.70M